Insider Selling: Encompass Health Co. (NYSE:EHC) EVP Sells $1,220,739.42 in Stock

Encompass Health Co. (NYSE:EHC) EVP John Patrick Darby sold 14,543 shares of the company’s stock in a transaction on Monday, May 6th. The shares were sold at an average price of $83.94, for a total value of $1,220,739.42. Following the completion of the transaction, the executive vice president now directly owns 84,773 shares in the company, valued at approximately $7,115,845.62. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Encompass Health Stock Up 1.3 %

Shares of Encompass Health stock opened at $86.37 on Friday. The firm has a market cap of $8.70 billion, a price-to-earnings ratio of 23.27, a P/E/G ratio of 1.30 and a beta of 0.92. The stock has a 50-day simple moving average of $79.76 and a 200-day simple moving average of $72.05. Encompass Health Co. has a 52-week low of $57.55 and a 52-week high of $86.60. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.37 and a quick ratio of 1.37.

Encompass Health (NYSE:EHC) last posted its earnings results on Wednesday, April 24th. The company reported $1.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.93 by $0.19. Encompass Health had a net margin of 7.60% and a return on equity of 18.01%. The firm had revenue of $1.32 billion during the quarter, compared to analysts’ expectations of $1.27 billion. During the same period in the previous year, the company earned $0.88 earnings per share. The company’s revenue was up 13.4% compared to the same quarter last year. On average, equities research analysts expect that Encompass Health Co. will post 4.1 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, July 15th. Shareholders of record on Monday, July 1st will be given a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a yield of 0.69%. The ex-dividend date of this dividend is Friday, June 28th. Encompass Health’s payout ratio is 16.22%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on EHC shares. William Blair reiterated an “outperform” rating on shares of Encompass Health in a research report on Wednesday, February 7th. Stephens reiterated an “overweight” rating and issued a $85.00 target price on shares of Encompass Health in a report on Tuesday, January 16th. Royal Bank of Canada restated an “outperform” rating and set a $83.00 price target on shares of Encompass Health in a report on Friday, February 9th. Mizuho upped their price target on shares of Encompass Health from $93.00 to $95.00 and gave the company a “buy” rating in a research report on Thursday, April 25th. Finally, Truist Financial lifted their price objective on shares of Encompass Health from $82.00 to $86.00 and gave the stock a “buy” rating in a research report on Friday, February 9th. Eight analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, Encompass Health has a consensus rating of “Buy” and a consensus price target of $90.29.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. Principal Securities Inc. acquired a new stake in shares of Encompass Health in the fourth quarter valued at about $25,000. Benjamin F. Edwards & Company Inc. increased its stake in Encompass Health by 360.2% during the fourth quarter. Benjamin F. Edwards & Company Inc. now owns 405 shares of the company’s stock valued at $27,000 after acquiring an additional 317 shares during the period. McGlone Suttner Wealth Management Inc. acquired a new position in Encompass Health in the 4th quarter valued at approximately $30,000. GAMMA Investing LLC bought a new stake in shares of Encompass Health in the 4th quarter worth approximately $33,000. Finally, C M Bidwell & Associates Ltd. acquired a new stake in shares of Encompass Health during the 3rd quarter worth approximately $35,000. Institutional investors and hedge funds own 97.25% of the company’s stock.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.